{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:48:07Z","timestamp":1786736887665,"version":"build-2736575974"},"reference-count":91,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Ophthalmol"],"published-print":{"date-parts":[[2020]]},"DOI":"10.4103\/ijo.ijo_1589_20","type":"journal-article","created":{"date-parts":[[2020,6,27]],"date-time":"2020-06-27T13:54:41Z","timestamp":1593266081000},"page":"1349","source":"Crossref","is-referenced-by-count":14,"title":["Potential ocular and systemic COVID-19 prophylaxis approaches for healthcare professionals"],"prefix":"10.4103","volume":"68","author":[{"given":"Sharon","family":"D'Souza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"VaitheeswaranGanesan","family":"Lalgudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Khamar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krati","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swaminathan","family":"Sethu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archana","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SantoshG","family":"Honavar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arkasubhra","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0301-4738.287500-1","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China, 2019","author":"Zhu","year":"2020","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0301-4738.287500-2","doi-asserted-by":"crossref","unstructured":"World Health Organization (WHO) Coronavirus disease (COVID-19) Situation Report \u2013 132. Data as received by WHO from national authorities by 10:00 CEST, 31 May 2020.","DOI":"10.46945\/bpj.10.1.03.01"},{"key":"key-10.4103\/0301-4738.287500-3","unstructured":"AIOS. AIOS Operational guidelines for Ophthalmic Practice during COVID-19 outbreak. 2020."},{"key":"key-10.4103\/0301-4738.287500-4","unstructured":"James C. Important coronavirus updates for ophthalmologists. Am Acad Ophthalmol 2020."},{"key":"key-10.4103\/0301-4738.287500-5","unstructured":"CDC. Interim Operational Considerations for Public Health Management of Healthcare Workers Exposed to or with Suspected or Confirmed COVID-19: Non-U.S. Healthcare Settings. 2020. Available forom: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/hcp\/non-us-settings\/public-health-management-hcw-exposed.html [Last accessed on 2020 May 14]."},{"key":"key-10.4103\/0301-4738.287500-6","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1056\/NEJMe2009758","article-title":"Asymptomatic transmission, the Achilles' heel of current strategies to control Covid-19","author":"Gandhi","year":"2020","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0301-4738.287500-7","unstructured":"AIOS. Ophthalmic Practice Guidelines in the Current Context of COVID-19. 2020."},{"key":"key-10.4103\/0301-4738.287500-8","first-page":"651","article-title":"Human coronaviruses: What do they cause?","author":"van","year":"2007","journal-title":"Antivir Ther"},{"key":"key-10.4103\/0301-4738.287500-9","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMra032498","article-title":"The severe acute respiratory syndrome","author":"Peiris","year":"2003","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0301-4738.287500-10","unstructured":"WHO. Modes of transmission of virus causing COVID-19: Implications for IPC precaution recommendations. 2020. Available from: https:\/\/www.who.int\/publications-detail\/modes-of-transmission-of-virus-causing-covid-19-implications-for-ipc-precaution-recommendations. [Last accessed on 2020 May 14]."},{"key":"key-10.4103\/0301-4738.287500-11","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1080\/22221751.2020.1729071","article-title":"Molecular and serological investigation of 2019-nCoV infected patients: Implication of multiple shedding routes","author":"Zhang","year":"2020","journal-title":"Emerg Microbes Infect"},{"key":"key-10.4103\/0301-4738.287500-12","doi-asserted-by":"crossref","unstructured":"Hoffmann M, Kleine-Weber H, Schroeder S, Kr\u00fcger N, Herrler T, Erichsen S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and Is blocked by a clinically proven protease inhibitor. Cell 2020;181:271-80.8.","DOI":"10.1016\/j.cell.2020.02.052"},{"key":"key-10.4103\/0301-4738.287500-13","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1128\/JVI.02202-13","article-title":"TMPRSS2 and ADAM17 cleave ACE2 differentially and only proteolysis by TMPRSS2 augments entry driven by the severe acute respiratory syndrome coronavirus spike protein","author":"Heurich","year":"2014","journal-title":"J Virol"},{"key":"key-10.4103\/0301-4738.287500-14","doi-asserted-by":"crossref","unstructured":"Hoffmann M, Kleine-Weber H, P\u00f6hlmann S. A multibasic cleavage site in the spike protein of SARS-CoV-2 is essential for infection of human lung cells. Mol Cell 2020;78:779-84.e5.","DOI":"10.1016\/j.molcel.2020.04.022"},{"key":"key-10.4103\/0301-4738.287500-15","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1038\/s41467-020-15562-9","article-title":"Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV","author":"Ou","year":"2020","journal-title":"Nat Commun"},{"key":"key-10.4103\/0301-4738.287500-16","doi-asserted-by":"crossref","unstructured":"Padmanabhan P, Desikan R, Dixit NM. Targeting TMPRSS2 and Cathepsin B\/L together may be synergistic against SARS-CoV-2 infection. ChemRxiv. 2020. doi: 1026434\/chemrxiv12213125v2.","DOI":"10.26434\/chemrxiv.12213125"},{"key":"key-10.4103\/0301-4738.287500-17","doi-asserted-by":"crossref","first-page":"e1002569","DOI":"10.1371\/journal.ppat.1002569","article-title":"Influenza virus respiratory infection and transmission following ocular inoculation in ferrets","author":"Belser","year":"2012","journal-title":"PLoS Pathog"},{"key":"key-10.4103\/0301-4738.287500-18","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1128\/JVI.01437-06","article-title":"Viral infection of the lungs through the eye","author":"Bitko","year":"2007","journal-title":"J Virol"},{"key":"key-10.4103\/0301-4738.287500-19","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/440435a","article-title":"Avian flu: Influenza virus receptors in the human airway","author":"Shinya","year":"2006","journal-title":"Nature"},{"key":"key-10.4103\/0301-4738.287500-20","first-page":"399","article-title":"H5N1 virus attachment to lower respiratory tract","author":"van","year":"2006","journal-title":"Science (New York, NY)"},{"key":"key-10.4103\/0301-4738.287500-21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.joco.2016.09.009","article-title":"Therapeutic targets of renin-angiotensin system in ocular disorders","author":"Choudhary","year":"2017","journal-title":"J Curr Ophthalmol","ISSN":"https:\/\/id.crossref.org\/issn\/2452-2325","issn-type":"print"},{"key":"key-10.4103\/0301-4738.287500-22","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/s41591-020-0868-6","article-title":"SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes","author":"Sungnak","year":"2020","journal-title":"Nat Med"},{"key":"key-10.4103\/0301-4738.287500-23","doi-asserted-by":"crossref","unstructured":"Zhou L, Xu Z, Castiglione GM, Soiberman US, Eberhart CG, Duh EJ. ACE2 and TMPRSS2 are expressed on the human ocular surface, suggesting susceptibility to SARS-CoV-2 infection. BioRxiv 2020. doi: 101101\/20200509086165.","DOI":"10.1101\/2020.05.09.086165"},{"key":"key-10.4103\/0301-4738.287500-24","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1136\/bjo.2003.035931","article-title":"The severe acute respiratory syndrome coronavirus in tears","author":"Loon","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0301-4738.287500-25","doi-asserted-by":"crossref","first-page":"e39","DOI":"10.1016\/S0140-6736(20)30313-5","article-title":"2019-nCoV transmission through the ocular surface must not be ignored","author":"Lu","year":"2020","journal-title":"Lancet (London, England)"},{"key":"key-10.4103\/0301-4738.287500-26","unstructured":"Post SCM. Chinese expert who came down with Wuhan coronavirus after saying it was controllable thinks he was infected through his eyes. 2020. Available from: https:\/\/www.scmp.com\/news\/china\/article\/3047394\/chinese-expert-who-came-down-wuhan-coronavirus-after-saying-it-was. [Last accessed on 2020 May 10]."},{"key":"key-10.4103\/0301-4738.287500-27","doi-asserted-by":"crossref","unstructured":"ISeah IYJ, Anderson DE, Kang AEZ, Wang L, Rao P, Young BE, et al. Assessing Viral Shedding and Infectivity of Tears in Coronavirus Disease 2019 (COVID-19) Patients. Ophthalmology 2020. doi: 10.1016\/j.ophtha.2020.03.026.","DOI":"10.1016\/j.ophtha.2020.03.026"},{"key":"key-10.4103\/0301-4738.287500-28","doi-asserted-by":"crossref","unstructured":"Seitzman GD, Doan T. No time for tears. Ophthalmology 2020;S0161-6420(20)30314-6. doi: 10.1016\/j.ophtha.2020.03.030.","DOI":"10.1016\/j.ophtha.2020.03.030"},{"key":"key-10.4103\/0301-4738.287500-29","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1001\/jamaophthalmol.2020.1291","article-title":"Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei Province, China","author":"Wu","year":"2020","journal-title":"JAMA Ophthalmol"},{"key":"key-10.4103\/0301-4738.287500-30","doi-asserted-by":"crossref","unstructured":"Xia J, Tong J, Liu M, Shen Y, Guo D. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection. J Med Virol 2020. doi: 10.1002\/jmv.25725.","DOI":"10.1002\/jmv.25725"},{"key":"key-10.4103\/0301-4738.287500-31","doi-asserted-by":"crossref","unstructured":"Sun X, Zhang X, Chen X, Chen L, Deng C, Zou X, et al. The infection evidence of SARS-COV-2 in ocular surface: A single-center cross-sectional study. medRxiv 2020. doi: 10.1101\/2020.02.26.20027938. [Last accessed on 2020 May 11].","DOI":"10.1101\/2020.02.26.20027938"},{"key":"key-10.4103\/0301-4738.287500-32","first-page":"e388","article-title":"The possibility of COVID-19 transmission from eye to nose","author":"Qing","year":"2020","journal-title":"Acta Ophthalmol"},{"key":"key-10.4103\/0301-4738.287500-33","first-page":"683","article-title":"What ophthalmologists should know about conjunctivitis in the COVID-19 pandemic?","author":"Shetty","year":"2020","journal-title":"Indian J Ophthalmol","ISSN":"https:\/\/id.crossref.org\/issn\/0301-4738","issn-type":"print"},{"key":"key-10.4103\/0301-4738.287500-34","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ijid.2020.03.017","article-title":"Prevalence of comorbidities and its effects in coronavirus disease 2019 patients: A systematic review and meta-analysis","author":"Yang","year":"2020","journal-title":"Int J Infect Dis"},{"key":"key-10.4103\/0301-4738.287500-35","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S2213-2600(20)30079-5","article-title":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: A single-centered, retrospective, observational study","author":"Yang","year":"2020","journal-title":"Lancet Respir Medic"},{"key":"key-10.4103\/0301-4738.287500-36","doi-asserted-by":"crossref","first-page":"5642","DOI":"10.1128\/JVI.78.11.5642-5650.2004","article-title":"pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN","author":"Yang","year":"2004","journal-title":"J Virol"},{"key":"key-10.4103\/0301-4738.287500-37","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/s41598-018-37703-3","article-title":"A pilot, open labelled, randomised controlled trial of hypertonic saline nasal irrigation and gargling for the common cold","author":"Ramalingam","year":"2019","journal-title":"Sci Rep"},{"key":"key-10.4103\/0301-4738.287500-38","doi-asserted-by":"crossref","first-page":"39956","DOI":"10.1038\/srep39956","article-title":"Universal and reusable virus deactivation system for respiratory protection","author":"Quan","year":"2017","journal-title":"Sci Rep"},{"key":"key-10.4103\/0301-4738.287500-39","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.3389\/fmicb.2018.02643","article-title":"The antihistamine drugs carbinoxamine maleate and chlorpheniramine maleate exhibit potent antiviral activity against a broad spectrum of influenza viruses","author":"Xu","year":"2018","journal-title":"Front Microbiol"},{"key":"key-10.4103\/0301-4738.287500-40","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/cr.2008.15","article-title":"SARS coronavirus entry into host cells through a novel clathrin- and caveolae-independent endocytic pathway","author":"Wang","year":"2008","journal-title":"Cell Res"},{"key":"key-10.4103\/0301-4738.287500-41","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1517\/14656566.2010.485609","article-title":"Olopatadine nasal spray for the treatment of seasonal allergic rhinitis in patients aged 6 years and older","author":"Roland","year":"2010","journal-title":"Expert Opin Pharmacother"},{"key":"key-10.4103\/0301-4738.287500-42","first-page":"268","article-title":"Azelastine nasal spray inhibiting sympathetic function on human nasal mucosa in patients with allergy rhinitis","author":"Cheng","year":"2019","journal-title":"Rhinology"},{"key":"key-10.4103\/0301-4738.287500-43","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/1743-422X-2-69","article-title":"Chloroquine is a potent inhibitor of SARS coronavirus infection and spread","author":"Vincent","year":"2005","journal-title":"Virol J"},{"key":"key-10.4103\/0301-4738.287500-44","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1473-3099(06)70361-9","article-title":"New insights into the antiviral effects of chloroquine","author":"Savarino","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"key-10.4103\/0301-4738.287500-45","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/s41565-020-0674-9","article-title":"Insights from nanomedicine into chloroquine efficacy against COVID-19","author":"Hu","year":"2020","journal-title":"Nat Nanotechol"},{"key":"key-10.4103\/0301-4738.287500-46","doi-asserted-by":"crossref","unstructured":"Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB. Pharmacologic treatments for coronavirus disease 2019 (COVID-19): A review. JAMA 2020. doi: 10.1001\/jama.2020.6019.","DOI":"10.1001\/jama.2020.6019"},{"key":"key-10.4103\/0301-4738.287500-47","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/S1473-3099(03)00806-5","article-title":"Effects of chloroquine on viral infections: An old drug against today's diseases?","author":"Savarino","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"key-10.4103\/0301-4738.287500-48","doi-asserted-by":"crossref","first-page":"e00293","DOI":"10.1002\/prp2.293","article-title":"Targeting endosomal acidification by chloroquine analogs as a promising strategy for the treatment of emerging viral diseases","author":"Al-Bari","year":"2017","journal-title":"Pharmacol Res Perspect"},{"key":"key-10.4103\/0301-4738.287500-49","doi-asserted-by":"crossref","first-page":"28423","DOI":"10.1038\/srep28423","article-title":"Trehalose, sucrose and raffinose are novel activators of autophagy in human keratinocytes through an mTOR-independent pathway","author":"Chen","year":"2016","journal-title":"Sci Rep"},{"key":"key-10.4103\/0301-4738.287500-50","first-page":"7627329","article-title":"Chloroquine protects human corneal epithelial cells from desiccation stress induced inflammation without altering the autophagy flux","author":"Shivakumar","year":"2018","journal-title":"Biomed Res Int"},{"key":"key-10.4103\/0301-4738.287500-51","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0166-3542(95)00047-P","article-title":"Role of trehalose dimycolate-induced interferon-alpha\/beta in the restriction of encephalomyocarditis virus growth in vivo and in peritoneal macrophage cultures","author":"Guillemard","year":"1995","journal-title":"Antiviral Res"},{"key":"key-10.4103\/0301-4738.287500-52","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3389\/fcimb.2017.00402","article-title":"Trehalose may decrease the transmission of Zika virus to the fetus by activating degradative autophagy","author":"Yuan","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"key":"key-10.4103\/0301-4738.287500-53","unstructured":"Hon S. Trehalose, an mTOR-independent Inducer of Autophagy, Inhibits HIV Infection in Primary Human Macrophage. UC San Diego, UC San Diego Electronic Theses and Dissertations. 2017. Available from: https:\/\/escholarship.org\/uc\/item\/77j0q7gd. [Last accessed on 2020 May 18]."},{"key":"key-10.4103\/0301-4738.287500-54","doi-asserted-by":"crossref","first-page":"10528","DOI":"10.1074\/jbc.M116.719286","article-title":"Trehalose alters subcellular trafficking and the metabolism of the alzheimer-associated amyloid precursor protein","author":"Tien","year":"2016","journal-title":"J Biol Chem"},{"key":"key-10.4103\/0301-4738.287500-55","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.jtos.2019.08.004","article-title":"Trehalose augments autophagy to mitigate stress induced inflammation in human corneal cells","author":"Panigrahi","year":"2019","journal-title":"Ocul Surf"},{"key":"key-10.4103\/0301-4738.287500-56","doi-asserted-by":"crossref","first-page":"e0124524","DOI":"10.1371\/journal.pone.0124524","article-title":"Trehalose-mediated autophagy impairs the anti-viral function of human primary airway epithelial cells","author":"Wu","year":"2015","journal-title":"PLoS One"},{"key":"key-10.4103\/0301-4738.287500-57","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/S0161-6420(02)01219-8","article-title":"Trehalose eye drops in the treatment of dry eye syndrome","author":"Matsuo","year":"2002","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.287500-58","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1080\/02713683.2019.1641824","article-title":"Efficacy and safety of topical chloroquine in mild to moderate dry eye disease","author":"Titiyal","year":"2019","journal-title":"Curr Eye Res"},{"key":"key-10.4103\/0301-4738.287500-59","first-page":"198","article-title":"Evaluation of the effects of chloroquine phosphate eye drops in patients with dry eye syndrome","author":"Bhavsar","year":"2011","journal-title":"Int J Biomed Adv Res"},{"key":"key-10.4103\/0301-4738.287500-60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5301\/ejo.5000836","article-title":"A randomized, controlled study of the efficacy and safety of a new eyedrop formulation for moderate to severe dry eye syndrome","author":"Chiambaretta","year":"2017","journal-title":"Eur J Ophthalmol"},{"key":"key-10.4103\/0301-4738.287500-61","doi-asserted-by":"crossref","unstructured":"Mishra S, Das S. Corneal ulcer following prolonged topical chloroquine phosphate. Delhi J Ophthalm 2018;28.42-3. doi: 10.7869\/djo.355.","DOI":"10.7869\/djo.355"},{"key":"key-10.4103\/0301-4738.287500-62","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/ICO.0000000000000358","article-title":"Tear film thickness after treatment with artificial tears in patients with moderate dry eye disease","author":"Schmidl","year":"2015","journal-title":"Cornea"},{"key":"key-10.4103\/0301-4738.287500-63","first-page":"663","article-title":"Topical olopatadine in the treatment of allergic conjunctivitis: A systematic review and meta-analysis","author":"Kam","year":"2017","journal-title":"Ocul Immunol Inflamm"},{"key":"key-10.4103\/0301-4738.287500-64","doi-asserted-by":"crossref","unstructured":"Mizoguchi T, Ozaki M, Ogino N. Efficacy of 0.05% epinastine and 0.1% olopatadine for allergic conjunctivitis as seasonal and preseasonal treatment. Clin Ophthalmol 2017;11:1747-53.","DOI":"10.2147\/OPTH.S141279"},{"key":"key-10.4103\/0301-4738.287500-65","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.coviro.2016.01.001","article-title":"Type I interferons in viral control and immune regulation","author":"Teijaro","year":"2016","journal-title":"Curr Opin Virol"},{"key":"key-10.4103\/0301-4738.287500-66","doi-asserted-by":"crossref","unstructured":"Shalhoub S. Interferon beta-1b for COVID-19. Lancet 2020;S0140-6736(20)31101-6. doi: 10.1016\/S0140-6736(20)31101-6.","DOI":"10.1016\/S0140-6736(20)31101-6"},{"key":"key-10.4103\/0301-4738.287500-67","doi-asserted-by":"crossref","first-page":"101300","DOI":"10.1016\/j.smim.2019.101300","article-title":"Global virus outbreaks: Interferons as 1st responders","author":"Wang","year":"2019","journal-title":"Semin Immunol"},{"key":"key-10.4103\/0301-4738.287500-68","doi-asserted-by":"crossref","unstructured":"Zhou Q, Wei X-S, Xiang X, Wang X, Wang Z-H, Chen V, et al. Interferon-a2b treatment for COVID-19. medRxiv 2020. doi: 10.1101\/2020040620042580.","DOI":"10.3389\/fimmu.2020.01061"},{"key":"key-10.4103\/0301-4738.287500-69","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.ophtha.2013.11.017","article-title":"et al.Surgical versus medical treatment of ocular surface squamous neoplasia: A comparison of recurrences and complications","author":"Nanji","year":"2014","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.287500-70","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000089211","article-title":"Inactivation of SARS coronavirus by means of povidone-iodine, physical conditions and chemical reagents","author":"Kariwa","year":"2006","journal-title":"Dermatology"},{"key":"key-10.4103\/0301-4738.287500-71","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s40121-018-0200-7","article-title":"In vitro bactericidal and virucidal efficacy of povidone-iodine gargle\/mouthwash against respiratory and oral tract pathogens","author":"Eggers","year":"2018","journal-title":"Infect Dis Ther"},{"key":"key-10.4103\/0301-4738.287500-72","doi-asserted-by":"crossref","first-page":"104724","DOI":"10.1016\/j.oraloncology.2020.104724","article-title":"Consideration of povidone-iodine as a public health intervention for COVID-19: Utilization as \u201cPersonal Protective Equipment\u201d for frontline providers exposed in high-risk head and neck and skull base oncology care","author":"Mady","year":"2020","journal-title":"Oral Oncol"},{"key":"key-10.4103\/0301-4738.287500-73","unstructured":"AAO. Special considerations for ophthalmic surgery during the COVID-19 pandemic. 2020. Available from: https:\/\/www.aao.org\/headline\/special-considerations-ophthalmic-surgery-during-c. [Last accessed on 2020 May 15]."},{"key":"key-10.4103\/0301-4738.287500-74","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1136\/bjo.87.9.1086","article-title":"Bilateral diffuse lamellar keratitis following bilateral simultaneous versus sequential laser in situ keratomileusis","author":"McLeod","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0301-4738.287500-75","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s12016-015-8469-8","article-title":"A critical review of the effects of hydroxychloroquine and chloroquine on the eye","author":"Costedoat-Chalumeau","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"key":"key-10.4103\/0301-4738.287500-76","doi-asserted-by":"crossref","first-page":"A3","DOI":"10.1016\/j.ajo.2020.03.028","article-title":"COVID-19 and Chloroquine\/Hydroxychloroquine: Is there ophthalmological concern?","author":"Marmor","year":"2020","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.287500-77","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1002\/ptr.6323","article-title":"Metabolic benefits of curcumin supplementation in patients with metabolic syndrome: A systematic review and meta-analysis of randomized controlled trials","author":"Azhdari","year":"2019","journal-title":"Phytother Res"},{"key":"key-10.4103\/0301-4738.287500-78","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jff.2017.12.017","article-title":"Antiviral potential of curcumin","author":"Mathew","year":"2018","journal-title":"J Funct Foods"},{"key":"key-10.4103\/0301-4738.287500-79","first-page":"186864","article-title":"A review on antibacterial, antiviral, and antifungal activity of curcumin","author":"Moghadamtousi","year":"2014","journal-title":"Biomed Res Int"},{"key":"key-10.4103\/0301-4738.287500-80","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/ptr.6226","article-title":"The effects of curcumin-containing supplements on biomarkers of inflammation and oxidative stress: A systematic review and meta-analysis of randomized controlled trials","author":"Tabrizi","year":"2019","journal-title":"Phytother Res"},{"key":"key-10.4103\/0301-4738.287500-81","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1021\/jm070295s","article-title":"Specific plant terpenoids and lignoids possess potent antiviral activities against severe acute respiratory syndrome coronavirus","author":"Wen","year":"2007","journal-title":"J Med Chem"},{"key":"key-10.4103\/0301-4738.287500-82","doi-asserted-by":"crossref","unstructured":"Hewlings SJ, Kalman DS. Curcumin: A review of its' effects on human health. Foods 2017;6:92.","DOI":"10.3390\/foods6100092"},{"key":"key-10.4103\/0301-4738.287500-83","doi-asserted-by":"crossref","first-page":"106004","DOI":"10.1016\/j.ijantimicag.2020.106004","article-title":"Amantadine disrupts lysosomal gene expression: A hypothesis for COVID19 treatment?","author":"Smieszek","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"key-10.4103\/0301-4738.287500-84","doi-asserted-by":"crossref","unstructured":"Daneshkhah A, Agrawal V, Eshein A, Subramanian H, Roy HK, Backman V. The possible role of vitamin D in suppressing cytokine storm and associated mortality in COVID-19 patients. medRxiv 2020. doi: 10.1101\/2020.04.08.20058578. [Last accessed on 2020 May 18].","DOI":"10.1101\/2020.04.08.20058578"},{"key":"key-10.4103\/0301-4738.287500-85","doi-asserted-by":"crossref","first-page":"E1248","DOI":"10.3390\/nu12051248","article-title":"Vitamin D's effect on immune function","author":"Martens","year":"2020","journal-title":"Nutrients"},{"key":"key-10.4103\/0301-4738.287500-86","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.3390\/nu7064240","article-title":"Modulation of the immune response to respiratory viruses by vitamin D","author":"Greiller","year":"2015","journal-title":"Nutrients"},{"key":"key-10.4103\/0301-4738.287500-87","doi-asserted-by":"crossref","first-page":"953","DOI":"10.3390\/nu10080953","article-title":"Development of vitamin D toxicity from overcorrection of vitamin D deficiency: A review of case reports","author":"Galior","year":"2018","journal-title":"Nutrients"},{"key":"key-10.4103\/0301-4738.287500-88","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.3390\/nu12041181","article-title":"Optimal nutritional status for a well-functioning immune system is an important factor to protect against viral infections","author":"Calder","year":"2020","journal-title":"Nutrients"},{"key":"key-10.4103\/0301-4738.287500-89","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ctim.2016.02.015","article-title":"Is one yoga style better than another.A systematic review of associations of yoga style and conclusions in randomized yoga trials?","author":"Cramer","year":"2016","journal-title":"Complement Ther Med"},{"key":"key-10.4103\/0301-4738.287500-90","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s10865-018-9914-y","article-title":"Yoga and immune system functioning: A systematic review of randomized controlled trials","author":"Falkenberg","year":"2018","journal-title":"J Behav Med"},{"key":"key-10.4103\/0301-4738.287500-91","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1177\/2047487314562741","article-title":"The effectiveness of yoga in modifying risk factors for cardiovascular disease and metabolic syndrome: A systematic review and meta-analysis of randomized controlled trials","author":"Chu","year":"2016","journal-title":"Eur J Prev Cardiol"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:47:23Z","timestamp":1786733243000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijo.IJO_1589_20"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":91,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020]]}},"alternative-id":["287500"],"URL":"https:\/\/doi.org\/10.4103\/ijo.ijo_1589_20","relation":{},"ISSN":["0301-4738"],"issn-type":[{"value":"0301-4738","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]}}}